Diziquit-MD 20/40 Tablet Substitute
Composition:
CINNARIZINE-20MG + DIMENHYDRINATE-40MG
Uses:
Vertigo
Medicinal Benefits:
Diziquit-MD 20/40 Tablet contains Cinnarizine and Dimenhydrinate. Diziquit-MD 20/40 Tablet belongs to a group of medicines called anti-vertigo drugs indicated for the symptomatic treatment of vertigo. Cinnarizine is a calcium antagonist that prevents the narrowing of the ear's blood vessels; this helps improve the blood flow in the ear. Dimenhydrinate is an antihistamine that blocks a chemical messenger known as histamine, thereby preventing problems with loss of balance. Together, Diziquit-MD 20/40 Tablet helps in reducing the symptoms of vertigo, such as dizziness and nausea. Diziquit-MD 20/40 Tablet can help you to carry out daily activities that are difficult when you have vertigo.
Diziquit-MD 20/40 Tablet contains Cinnarizine and Dimenhydrinate. Cinnarizine prevents the narrowing of the blood vessels in the ear; this improves the blood flow in the ear. Dimenhydrinate works by blocking the action of a chemical messenger known as histamine, thus prevents problems with loss of balance.
Dry mouth could be a side-effect of Diziquit-MD 20/40 Tablet . Limiting caffeine intake, avoiding smoking and mouthwashes containing alcohol, drinking water regularly, and chewing sugar-free gum/candy might stimulate saliva and prevent drying of the mouth.
Talk to your doctor before taking Diziquit-MD 20/40 Tablet with anti-hypertensive medicines along with Diziquit-MD 20/40 Tablet as Diziquit-MD 20/40 Tablet might lower their effect. Regular monitoring of blood pressure levels is advised while taking Diziquit-MD 20/40 Tablet .
Please do not stop taking Diziquit-MD 20/40 Tablet on your own as it might cause recurring symptoms. Continue taking Diziquit-MD 20/40 Tablet for as long as your doctor prescribes it. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Diziquit-MD 20/40 Tablet .
Consult your doctor before taking Diziquit-MD 20/40 Tablet if you have glaucoma (raised pressure in the eye). Do not take Diziquit-MD 20/40 Tablet if you have angle-closure glaucoma (a specific type of eye disease).
Patients should not take Diziquit-MD 20/40 Tablet with pre-existing extrapyramidal movement disorders such as Parkinson’s disease.